>>1808591 (lb)
Obama:
“Let’s Me Be Clear: ISIL Is Not ‘Islamic'”
>04f192
Following her loss to Valadao, Renteria went to work for Hillary Rodham Clinton as the political director on her 2016 presidential campaign.[17]
https://infogalactic.com/info/Amanda_Renteria#2016_Clinton_campaign
FINALLY!
also one key to anti-aging research, specifically "naive" T cells :
>http://www.anti-agingfirewalls.com/2011/09/11/aging-and-the-immune-system-–-focus-on-naive-t-cells/
naive cells that have matured, left the bone marrow or thymus, have entered the lymphatic system, but that have yet to encounter their cognate antigen,
And who always has lots of T cells in stock?
Quite possible.
We still need to figure how the Red Cross is relevant to Iran, Pakistan, NK & …….. .
What's RC's "product"?
Very interesting.
>Allogene is working on allogeneic CAR-T treatments, which are made from donor T cells and can be used "off the shelf."
>Longtime Cowen analyst Eric Schmidt is joining Arie Belldegrun's latest CAR-T startup, Allogene, as its chief financial officer.
>Arie Belldegrun's latest CAR-T startup, Allogene
Well, look at this:
https://infogalactic.com/info/Arie_Belldegrun
Arie S. Belldegrun (born 1949), MD, FACS, is an Israeli-born American urologic oncologist, businessman, and investor.
He received his medical degree from the Hadassah Medical Center at Hebrew University of Jerusalem in 1974, and conducted his post-graduate studies at the Weizmann Institute of Science in 1979.[1] He completed his Urologic Surgery residency at Harvard Medical School in 1985, and his Surgical Oncology fellowship at the National Cancer Institute in 1988.[1]
Belldegrun is the Director of the UCLA Institute of Urologic Oncology, Professor of Urology, and Chief of the Division of Urologic Oncology at the David Geffen School of Medicine.[4][5][6]
Belldegrun is the Chairman, President and CEO of Kite Pharma (NASDAQ: KITE) which he founded in 2009. Kite Pharma is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors.[12]
Preceded by the Red Lion.
Coincidence that 1st 2 things NK & SK agreed to hold talks on were the military the R.C.?
https://specialoperations.com/33145/north-and-south-korea-agree-to-hold-military-red-cross-talks/
Very nice dig.
>her challenger the Bavarian Governor.
Sick of looking at her, but not sure he would be any better.
Know nada about German politics, but gotta imagine he's also owned lock, stock & barrel.